Related Experiment Video
Updated: Sep 3, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Src Family Kinases: A Potential Therapeutic Target for Acute Kidney Injury
Nannan Li1, Guoxin Lin2, Hao Zhang1
1Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Abstract:
Src family kinases (SFKs) are non-receptor tyrosine kinases and play a key role in regulating signal transduction. The mechanism of SFKs in various tumors has been widely studied, and there are more and more studies on its role in the kidney. Acute kidney injury (AKI) is a disease with complex pathogenesis, including oxidative stress (OS), inflammation, endoplasmic reticulum (ER) stress, autophagy, and apoptosis. In addition, fibrosis has a significant impact on the progression of AKI to developing chronic kidney disease (CKD). The mortality rate of this disease is very high, and there is no effective treatment drug at present. In recent years, some studies have found that SFKs, especially Src, Fyn, and Lyn, are involved in the pathogenesis of AKI. In this paper, the structure, function, and role of SFKs in AKI are discussed. SFKs play a crucial role in the occurrence and development of AKI, making them promising molecular targets for the treatment of AKI.
Insights
Src family kinases (SFKs) are crucial in kidney injury. Targeting SFKs like Src, Fyn, and Lyn offers a promising therapeutic strategy for acute kidney injury (AKI).
Area of Science:
- Molecular Biology
- Nephrology
- Biochemistry
Background:
- Src family kinases (SFKs) are non-receptor tyrosine kinases vital for signal transduction.
- SFKs, including Src, Fyn, and Lyn, are increasingly implicated in kidney disease pathogenesis.
- Acute kidney injury (AKI) involves complex mechanisms like oxidative stress, inflammation, ER stress, autophagy, and apoptosis, often leading to fibrosis and chronic kidney disease (CKD).
Purpose of the Study:
- To review the structure, function, and role of SFKs in the context of AKI.
- To highlight SFKs as potential therapeutic targets for AKI treatment.
Main Methods:
- Literature review and synthesis of existing research on SFKs and AKI.
Main Results:
- SFKs play a significant role in the development and progression of AKI.
- Specific SFKs, notably Src, Fyn, and Lyn, are involved in AKI pathogenesis.
Conclusions:
- SFKs are critical mediators in AKI.
- Targeting SFKs presents a promising avenue for developing novel AKI therapeutics.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

